Ligand Pharmaceuticals Statistics
Total Valuation
BIT:1AMSC has a market cap or net worth of EUR 2.10 billion. The enterprise value is 1.93 billion.
Market Cap | 2.10B |
Enterprise Value | 1.93B |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 45.16M |
Shares Outstanding | n/a |
Shares Change (YoY) | +26.46% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 41.33M |
Valuation Ratios
The trailing PE ratio is 161.57 and the forward PE ratio is 84.58.
PE Ratio | 161.57 |
Forward PE | 84.58 |
PS Ratio | 9.69 |
PB Ratio | 7.41 |
P/TBV Ratio | 8.84 |
P/FCF Ratio | 94.83 |
P/OCF Ratio | 85.14 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 110.99, with an EV/FCF ratio of 86.85.
EV / Earnings | 147.99 |
EV / Sales | 8.72 |
EV / EBITDA | 110.99 |
EV / EBIT | 179.08 |
EV / FCF | 86.85 |
Financial Position
The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.31 |
Quick Ratio | 2.49 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.19 |
Debt / FCF | 0.14 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is 3.20%.
Return on Equity (ROE) | 6.41% |
Return on Assets (ROA) | 2.24% |
Return on Invested Capital (ROIC) | 3.20% |
Return on Capital Employed (ROCE) | 3.57% |
Revenue Per Employee | 381,433 |
Profits Per Employee | 22,868 |
Employee Count | 569 |
Asset Turnover | 0.74 |
Inventory Turnover | 3.08 |
Taxes
Income Tax | -3.12M |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 85.59 |
Average Volume (20 Days) | 28 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIT:1AMSC had revenue of EUR 217.04 million and earned 13.01 million in profits. Earnings per share was 0.34.
Revenue | 217.04M |
Gross Profit | 63.71M |
Operating Income | 10.57M |
Pretax Income | 9.89M |
Net Income | 13.01M |
EBITDA | 15.49M |
EBIT | 10.57M |
Earnings Per Share (EPS) | 0.34 |
Balance Sheet
The company has 177.02 million in cash and 3.20 million in debt, giving a net cash position of 173.82 million.
Cash & Cash Equivalents | 177.02M |
Total Debt | 3.20M |
Net Cash | 173.82M |
Net Cash Per Share | n/a |
Equity (Book Value) | 283.65M |
Book Value Per Share | 6.28 |
Working Capital | 207.38M |
Cash Flow
In the last 12 months, operating cash flow was 24.69 million and capital expenditures -2.52 million, giving a free cash flow of 22.17 million.
Operating Cash Flow | 24.69M |
Capital Expenditures | -2.52M |
Free Cash Flow | 22.17M |
FCF Per Share | n/a |
Margins
Gross margin is 29.35%, with operating and profit margins of 4.87% and 6.00%.
Gross Margin | 29.35% |
Operating Margin | 4.87% |
Pretax Margin | 4.56% |
Profit Margin | 6.00% |
EBITDA Margin | 7.14% |
EBIT Margin | 4.87% |
FCF Margin | 10.22% |
Dividends & Yields
BIT:1AMSC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -26.46% |
Shareholder Yield | n/a |
Earnings Yield | 0.62% |
FCF Yield | 1.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 7 |